Weighted Average Number of Shares Outstanding, Basic of AGILE THERAPEUTICS INC from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Agile Therapeutics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q1 2014 to Q2 2024.
  • Agile Therapeutics Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Jun 2024 was 6.86M shares, a 287% increase year-over-year.
  • Agile Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 2.16M shares, a 399% increase from 2022.
  • Agile Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 432K shares, a 791% increase from 2021.
  • Agile Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 48.5K shares, a 97.7% decline from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

AGILE THERAPEUTICS INC Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 6.86M +5.09M +287% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2024
Q1 2024 4.63M +3.72M +408% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024
Q4 2023 2.16M +1.72M +399% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2024
Q3 2023 2.95M +2.21M +299% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 1.77M +1.68M +1862% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 912K +850K +1364% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 432K +384K +791% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 740K -1.6M -68.4% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 90.2K -2.13M -95.9% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 62.3K -2.13M -97.2% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 48.5K 01 Oct 2021 31 Dec 2021 10-K 28 Mar 2024
Q3 2021 2.34M -85M -97.3% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 2.22M 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 2.19M 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q3 2020 87.4M 01 Jul 2020 30 Sep 2020 10-Q/A 30 Dec 2021
Q1 2015 21.3M +21.2M +19920% 01 Jan 2015 31 Mar 2015 10-Q 12 May 2015
Q1 2014 106K 01 Jan 2014 31 Mar 2014 10-Q 12 May 2015

AGILE THERAPEUTICS INC Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 2.16M +1.72M +399% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2024
2022 432K +384K +791% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 48.5K -2.07M -97.7% 01 Jan 2021 31 Dec 2021 10-K 28 Mar 2024
2020 2.12M -47.3M -95.7% 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2023
2019 49.4M 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.